Your browser doesn't support javascript.
loading
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
Belli, C; Penault-Llorca, F; Ladanyi, M; Normanno, N; Scoazec, J-Y; Lacroix, L; Reis-Filho, J S; Subbiah, V; Gainor, J F; Endris, V; Repetto, M; Drilon, A; Scarpa, A; André, F; Douillard, J-Y; Curigliano, G.
Affiliation
  • Belli C; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
  • Penault-Llorca F; University Clermont Auvergne, INSERM U1240, Centre Jean Perrin, Department of BioPathology, Clermont-Ferrand, France.
  • Ladanyi M; Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy.
  • Scoazec JY; AMMICa, CNRS-UMS 3655 and INSERM-US23, Gustave Roussy, Villejuif, France; Department of Pathology and Translational Research, Gustave Roussy Cancer Centre, Villejuif, France.
  • Lacroix L; Translational Research Laboratory and Biobank, Gustave Roussy, Villejuif, France; Inserm U981, Gustave Roussy, Villejuif, France; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gainor JF; Massachusetts General Hospital, Boston, USA.
  • Endris V; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Repetto M; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Drilon A; Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
  • Scarpa A; ARC-Net Research Centre and Department of Diagnostics and Public Health - Section of Pathology, University of Verona, Verona, Italy.
  • André F; Gustave Roussy Cancer Center, Villejuif, France.
  • Douillard JY; Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland.
  • Curigliano G; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: education@esmo.org.
Ann Oncol ; 32(3): 337-350, 2021 03.
Article de En | MEDLINE | ID: mdl-33455880
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines proto-oncogènes c-ret / Oncologie médicale Type d'étude: Guideline Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines proto-oncogènes c-ret / Oncologie médicale Type d'étude: Guideline Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni